CollPlant Biotechnologies (CLGN) EBT Margin Growth (3y) (2020 - 2026)
CollPlant Biotechnologies (CLGN) EBT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 6,685.00 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2,054.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8,006.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 9,980.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 31,363.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -5,319.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -9,922.00 |
| 10 | CollPlant Biotechnologies | 4.13 Mn | 4.13 Mn | -243,000.00 | -507,983.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -501,470.00 |
| Dec 31, 2025 | -650,845.00 |
| Sep 30, 2025 | -45,546.00 |
| Jun 30, 2025 | 811,633.00 |
| Dec 31, 2024 | 7.08 Mn |
| Sep 30, 2024 | -16.38 Mn |
| Jun 30, 2024 | 206,663.00 |
| Mar 31, 2024 | 422,018.00 |
| Dec 31, 2023 | -182,090.00 |
| Sep 30, 2023 | -1.69 Mn |
| Jun 30, 2023 | 28,564.00 |
| Mar 31, 2023 | 48,469.00 |
| Dec 31, 2022 | -5.09 Mn |
| Sep 30, 2022 | -363,119.00 |
| Jun 30, 2022 | -609,008.00 |
| Dec 31, 2021 | -7.37 Mn |
| Sep 30, 2021 | 5.08 Mn |
| Jun 30, 2021 | 51,281.00 |
| Mar 31, 2021 | -86,016.00 |
| Dec 31, 2020 | -47,867.00 |